IRIS
Zambelli, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.024
AS - Asia 3.528
EU - Europa 1.437
SA - Sud America 947
Continente sconosciuto - Info sul continente non disponibili 217
AF - Africa 205
OC - Oceania 21
Totale 10.379
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.859
SG - Singapore 1.904
CN - Cina 747
BR - Brasile 737
IT - Italia 537
VN - Vietnam 430
FI - Finlandia 189
NG - Nigeria 145
IE - Irlanda 135
DE - Germania 124
HK - Hong Kong 106
GB - Regno Unito 100
FR - Francia 96
AR - Argentina 89
IN - India 74
CA - Canada 69
NL - Olanda 48
MX - Messico 47
ID - Indonesia 44
RU - Federazione Russa 40
EC - Ecuador 36
BD - Bangladesh 31
IQ - Iraq 30
SE - Svezia 28
PL - Polonia 24
CL - Cile 21
ES - Italia 21
JP - Giappone 20
ZA - Sudafrica 20
AU - Australia 19
CO - Colombia 19
UA - Ucraina 19
PK - Pakistan 17
PY - Paraguay 17
MA - Marocco 14
UZ - Uzbekistan 12
VE - Venezuela 12
TR - Turchia 11
KZ - Kazakistan 10
CR - Costa Rica 9
CZ - Repubblica Ceca 9
IL - Israele 9
LT - Lituania 8
MY - Malesia 8
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
JM - Giamaica 7
NO - Norvegia 7
PA - Panama 7
BE - Belgio 6
DO - Repubblica Dominicana 6
KE - Kenya 6
OM - Oman 6
RO - Romania 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AT - Austria 5
BG - Bulgaria 5
BH - Bahrain 5
BO - Bolivia 5
GT - Guatemala 5
HN - Honduras 5
JO - Giordania 5
PE - Perù 5
PH - Filippine 5
TH - Thailandia 5
AZ - Azerbaigian 4
CH - Svizzera 4
NP - Nepal 4
PT - Portogallo 4
TN - Tunisia 4
TW - Taiwan 4
UY - Uruguay 4
AL - Albania 3
DK - Danimarca 3
DZ - Algeria 3
GR - Grecia 3
IR - Iran 3
KG - Kirghizistan 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BY - Bielorussia 2
CY - Cipro 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
HR - Croazia 2
KR - Corea 2
MD - Moldavia 2
NI - Nicaragua 2
SY - Repubblica araba siriana 2
AO - Angola 1
BB - Barbados 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
EU - Europa 1
GY - Guiana 1
HU - Ungheria 1
KI - Kiribati 1
Totale 10.154
Salva come PNG Salva come JPEG
Città #
Singapore 790
Ashburn 427
The Dalles 314
San Jose 270
Shanghai 244
New York 233
Chandler 219
Beijing 193
Milan 190
Helsinki 189
Council Bluffs 176
Ho Chi Minh City 169
Benin City 143
Dublin 134
Dallas 132
Princeton 119
Lawrence 113
Los Angeles 104
Hong Kong 96
Hanoi 92
Santa Clara 84
Wilmington 82
Rome 74
Boardman 64
São Paulo 62
Paris 59
London 44
Buffalo 38
Amsterdam 36
Phoenix 33
Rio de Janeiro 29
San Mateo 29
Philadelphia 24
Figino 21
Warsaw 21
Seattle 20
Charlotte 19
Florence 19
Brasília 18
Mexico City 18
Montreal 18
Brooklyn 17
Da Nang 17
Turin 17
Ann Arbor 16
Belo Horizonte 16
Mumbai 16
Naples 16
Fairfield 15
Haiphong 15
Brownsville 14
Chennai 14
Atlanta 13
Chicago 13
Guayaquil 13
Leawood 13
Bologna 12
Johannesburg 12
Quito 12
Salvador 12
Tokyo 12
Boston 11
Fortaleza 11
Tashkent 11
Thái Bình 11
Toronto 11
Buenos Aires 10
Falkenstein 10
Frankfurt am Main 10
Houston 10
Montgomery Village 10
Porto Alegre 10
San Antonio 10
San Francisco 10
Asunción 9
Baghdad 9
Cincinnati 9
Curitiba 9
Munich 9
Orem 9
Poplar 9
Venice 9
Assago 8
Biên Hòa 8
Denver 8
Milwaukee 8
Newark 8
Pasadena 8
South Jordan 8
Thái Nguyên 8
Woodbridge 8
Dearborn 7
Hangzhou 7
Hải Dương 7
Kyiv 7
Moscow 7
Oxnard 7
Pittsburgh 7
Pune 7
Queens 7
Totale 5.786
Salva come PNG Salva come JPEG
Nome #
Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants 138
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms 122
Breast and renal cancer-Derived endothelial colony forming cells share a common gene signature 116
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients 104
34. Trabectedin and indole-3-carbinol combination in heavily pretreated metastatic breast cancer: Results of a pilot clinical study 102
Multinational characterization of neurological phenotypes in patients hospitalized with COVID-19 101
Precision medicine in Salivary Gland Carcinoma: Insights from breast and prostate cancer 101
ACUTE UPPER GASTROINTESTINAL BLEEDING (AUGB) IN ITALY: AN INTERIM ANALYSIS OF THE ORGANIZATIONAL ASPECTS CARING AN EVOLVING DISEASE 94
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study 93
Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen - A pilot study in patients with refractory malignancies 93
Predicting and preventing cardiotoxicity in the era of breast cancer targeted therapies. Novel molecular tools for clinical issues. 91
27P * Common gene signature expressed by breast and kidney cancers-derived endothelial colony forming cells 87
Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter? 86
A Remote Monitoring System to Optimize the Home Management of Oral Anticancer Therapies (ONCO-TreC): Prospective Training-Validation Trial 86
Adipose-derived mesenchymal stem cells (ASCs) may favour breast cancer recurrence via HGF/c-Met signaling 85
Cellular and molecular determinants of all‐ trans retinoic acid sensitivity in breast cancer: Luminal phenotype and α expression 84
Clinical toxicity of cryopreserved circulating progenitor cells infusion 83
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score 82
Adding pertuzumab to adjuvant therapy for high-risk HER2-positive early breast cancer in APHINITY: a GRADE analysis 82
A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast Cancer 80
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study 80
Analysis of SEMA6B gene expression in breast cancer: Identification of a new isoform 79
Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast Cancer Undergoing Treatment with Aromatase Inhibitors 79
Pulmonary function and complications following chemotherapy and stem cell support in breast cancer 78
Prospective multicenter quality assessment of endotherapy of biliary stones: does center volume matter? 78
Clinical Review on the Management of Breast Cancer Visceral Crisis 77
Alternative Splicing in Adhesion- and Motility-Related Genes in Breast Cancer 77
A male patient with acromegaly and breast cancer: treating acromegaly to control tumor progression 77
Monitoring changing patterns in HER2 addiction by liquid biopsy in advanced breast cancer patients 76
Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe 76
Analysis of Italian BRCA1/2 Pathogenic Variants Identifies a Private Spectrum in the Population from the Bergamo Province in Northern Italy 76
TRANSFUSION STRATEGY AND DEATH RISK IN PATIENTS WITH ACUTE NON-VARICEAL UPPER GASTRO INTESTINAL BLEEDING (NV-UGIB) IN ITALY: A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY 75
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective 75
In vitro Cytotoxic Effect of Trabectedin on JMML AND CMML Cell Populations 74
PREDICTIVE FACTORS OF MORTALITY IN ACUTE GASTROINTESTINAL BLEEDING IN ITALY (AUGIB): A NEW PRE-ENDOSCOPY PROGNOSTIC MODEL FROM A MULTICENTER STUDY 74
Phase II study with ifosfamide, carboplatin, etoposide (ICE regimen) at intermediate dosage for advanced non small cell lung cancer (NSCLC) 74
Targeting triple negative breast cancer: Is p53 the answer? 74
Opportunities and Challenges of Synthetic Data Generation in Oncology 73
Cellular and molecular determinants of breast cancer sensitivity to all-trans retinoic acid: Identification of a gene expression fingerprint predicting responsiveness 73
Evaluation of infectious complications and immune recovery following high-dose chemotherapy (HDC) and autologous peripheral blood progenitor cell transplantation (PBPC-T) in 148 breast cancer patients 72
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study 72
Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry 71
Circulating CD33+large mononuclear cells contain three distinct populations with phenotype of putative antigen-presenting cells including myeloid dendritic cells and CD14+monocytes with their CD16+subset 71
Bone-Active Drugs in Pre-Menopausal Women with Breast Cancer Under Hormone Deprivation Therapies 70
A randomized multicenter study of optimal circadian time of vinorelbine combined with chronomodulated 5-fluorouracil in pretreated metastatic breast cancer patients: EORTC trial 05971 70
Erlotinib administration for advanced non-small cell lung cancer during the first 2 months of unrecognized pregnancy 70
STEM-CELL FACTOR AND INTERLEUKIN-6, ALONE OR IN COMBINATION WITH GRANULOCYTE-COLONY-STIMULATING FACTOR, DO NOT AFFECT THE GROWTH OF SOLID TUMOR-CELL LINES 70
Incidence and relevance of QTc-interval prolongation caused by tyrosine kinase inhibitors 70
Incidence of human cytomegalovirus infection in patients with refractory solid tumors receiving nonmyeloablative allogeneic stem cell transplants versus recipients of standard SCT for hematologic malignancies 69
Relationship between size and thiazole orange fluorescence of platelets in patients undergoing high-dose chemotherapy 69
A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast Cancer 69
Predictive Factors of Lapatinib and Capecitabine Activity in Patients with HER2-Positive, Trastuzumab-Resistant Metastatic Breast Cancer: Results from the Italian Retrospective Multicenter HERLAPAC Study 69
An ICT infrastructure to integrate clinical and molecular data in oncology research 68
Short commentaries on data published by Petit et al. on locoregional risk after lipofilling in breast cancer patients 68
Correction: Everolimus (Eve) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9:77 (34639-34640) DOI: 10.18632/oncotarget.25874) 67
From cancer patients to cancer survivors: the issue of Cardioncology--a biological perspective. 67
trattamento conservativo dell' osteonecrosi spontaea del ginocchio in fase iniziale con campi pulsati: studio a 2 anni di follow-up minimo 67
T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer 67
Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study 67
Epithelial tumour cell detection and the unsolved problems of nested RT-PCR: A new sensitive one step method without false positive results 66
Poor outcome of patients with resectable breast cancer receiving adjuvant high-dose sequential chemotherapy following preoperative treatment 66
Trabectedin for the treatment of breast cancer 66
Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer 66
Four-day infusion of fluorouracil plus vinorelbine as salvage treatment of heavily pretreated metastatic breast cancer 65
OUTPATIENT MANAGEMENT OF PATIENTS WITH GLASGOW-BLATCHFORD BLEEDING SCORE LOW-RISK UPPER-GASTROINTESTINAL HEMORRHAGE: A MULTICENTER VALIDATION STUDY IN ITALY 64
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study 64
No correlation between plasma D-dimer levels and lymph node involvement in operable breast cancer 64
From seaside to bedside: Current evidence and future perspectives in the treatment of breast cancer using marine compounds 63
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 63
Gene expression profiling and prediction of response to hormonal neoadjuvant treatment with anastrozole in surgically resectable breast cancer 63
Absence of the K303R estrogen receptor alpha mutation in breast cancer patients exhibiting different responses to aromatase inhibitor anastrozole neoadjuvant treatment 63
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer 63
Multi-institutional retrospective analysis of clinical and pathological factors predicting resistance to lapatinib-based therapy in HER2 positive metastatic breast cancer (HER2+ MBC) 63
Trastuzumab-Related Cardiotoxicity in Early Breast Cancer: A Cohort Study 63
Regulation of aromatase expression in breast cancer treated with anastrozole neoadjuvant therapy 63
ONCO-i2b2: Improve Patients Selection through Case-Based Information Retrieval TechniquesData Integration in the Life Sciences 63
AurkA controls self-renewal of breast cancer-initiating cells promoting wnt3a stabilization through suppression of miR-128 62
Remodelling of the Ca2+ signalling machinery in endothelial progenitor cells isolated from breast cancer patients 62
SAFETY PROFILE AND TOLERABILITY OF 'TRABECTEDIN AND INDOLE-3-CARBINOL COMBINATION IN REFRACTORY ADVANCED BREAST CANCER. PRELIMINARY RESULTS OF PHASE 1 CLINICAL STUDY 62
The Role of Female Reproductive Hormones in the Association between Migraine and Breast Cancer: An Unanswered Question 61
An epirubicin/paclitaxel combination mobilizes large amounts of hematopoietic progenitor cells in patients with metastatic breast cancer showing optimal response to the same chemotherapy regimen 61
What Every Reader Should Know About Studies Using Electronic Health Record Data but May Be Afraid to Ask 61
Retinoids and breast cancer: from basic studies to the clinic and back again 61
Common Misconceptions about Diet and Breast Cancer: An Unclear Issue to Dispel 60
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 60
T-cell dynamics after high-dose chemotherapy in adults: elucidation of the elusive CD8(+) subset reveals multiple homeostatic T-cell compartments with distinct implications for immune competence 60
Efficacy and safety of T-DM1 in the ‘common-practice’ of HER2+ advanced breast cancer setting: a multicenter study 60
Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM) 60
Evolving phenotypes of non-hospitalized patients that indicate long COVID 60
Digital innovations in breast cancer care: exploring the potential and challenges of digital therapeutics and clinical decision support systems 60
MORTALITY IN UPPER GASTROINTESTINAL BLEEDING IN ITALY: DATA FROM NATIONAL SURVEY 59
Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow 59
Prevalence of treatment-related adverse events (TRAEs) with antibody-drug conjugates in metastatic breast cancer patients: A systematic review and meta-analysis 59
Heterogeneity of triple-negative breast cancer: understanding the Daedalian labyrinth and how it could reveal new drug targets 58
Free mobility of medical oncologists across the European Union: still a false myth 58
Cytotoxic chemotherapy preceding apheresis of peripheral blood progenitor cells can affect the early reconstitution phase of naive T cells after autologous transplantation 58
Commentary: Improvement in diagnostic-therapeutic care pathways for women with migraine: an Italian Delphi panel 58
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study 57
Patient similarity by joint matrix trifactorization to identify subgroups in acute myeloid leukemia 57
Long term survival of HER2-positive early breast cancer treated with trastuzumab-based adjuvant regimen: a large cohort study from clinical practice 57
Totale 7.256
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.121
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.121
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022470 0 1 4 17 5 6 7 12 183 80 136 19
2022/20231.057 248 48 135 86 98 62 5 53 100 140 67 15
2023/20241.012 71 80 157 47 36 197 54 46 27 31 100 166
2024/20251.583 43 7 12 20 23 273 104 85 218 418 172 208
2025/20265.311 655 290 374 740 243 154 1.011 242 327 366 272 637
2026/2027806 553 253 0 0 0 0 0 0 0 0 0 0
Totale 10.379